These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17381757)

  • 1. Application of flow cytometry for the determination of minimal inhibitory concentration of several antibacterial agents on Mycoplasma hyopneumoniae.
    Assunção P; Antunes NT; Rosales RS; Poveda C; de la Fe C; Poveda JB; Davey HM
    J Appl Microbiol; 2007 Apr; 102(4):1132-7. PubMed ID: 17381757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric method for the assessment of the minimal inhibitory concentrations of antibacterial agents to Mycoplasma agalactiae.
    Assunção P; Antunes NT; Rosales RS; de la Fe C; Poveda C; Poveda JB; Davey HM
    Cytometry A; 2006 Oct; 69(10):1071-6. PubMed ID: 16998868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Mycoplasma hyopneumoniae growth by flow cytometry.
    Assunção P; Diaz R; Comas J; de Galarreta CM; González-Llamazares OR; Poveda JB
    J Appl Microbiol; 2005; 98(5):1047-54. PubMed ID: 15836473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of tilmicosin to prevent adherence of Mycoplasma hyopneumoniae to cilia using a differentiated swine respiratory epithelial culture system.
    Thacker EL; Young TF; Erickson BZ; DeBey MC
    Vet Ther; 2001; 2(4):293-300. PubMed ID: 19746651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015-2016.
    de Jong A; Youala M; Klein U; El Garch F; Moyaert H; Simjee S; Maes D; Gyuranecz M; Pridmore A; Thomson JR; Ayling RD;
    Vet Microbiol; 2021 Feb; 253():108973. PubMed ID: 33418394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae.
    Tavío MM; Poveda C; Assunção P; Ramírez AS; Poveda JB
    Vet Rec; 2014 Nov; 175(21):539. PubMed ID: 25185108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C; Ewing M; Aarabi SY
    Avian Dis; 2001; 45(2):456-60. PubMed ID: 11417828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
    Jordan FT; Forrester CA; Ripley PH; Burch DG
    Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method.
    Felde O; Kreizinger Z; Sulyok KM; Hrivnák V; Kiss K; Jerzsele Á; Biksi I; Gyuranecz M
    PLoS One; 2018; 13(12):e0209030. PubMed ID: 30533041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin.
    Huang Z; Mao C; Wei Y; Gu X; Cai Q; Shen X; Ding H
    PLoS One; 2020; 15(6):e0220350. PubMed ID: 32544163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tiamulin against porcine mycoplasmas.
    Goodwin RF
    Res Vet Sci; 1985 Jan; 38(1):124-5. PubMed ID: 3975477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae.
    Hannan PC; Windsor HM; Ripley PH
    Res Vet Sci; 1997; 63(2):157-60. PubMed ID: 9429250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibilities of field isolates of Mycoplasma agalactiae to oxytetracycline, tylosin, enrofloxacin, spiramycin and lincomycin-spectinomycin.
    Loria GR; Sammartino C; Nicholas RA; Ayling RD
    Res Vet Sci; 2003 Aug; 75(1):3-7. PubMed ID: 12801456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology.
    Hannan PC
    Vet Res; 2000; 31(4):373-95. PubMed ID: 10958240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae and Mycoplasma bovis isolated in Europe.
    Klein U; de Jong A; Moyaert H; El Garch F; Leon R; Richard-Mazet A; Rose M; Maes D; Pridmore A; Thomson JR; Ayling RD
    Vet Microbiol; 2017 May; 204():188-193. PubMed ID: 28532800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric determination of the effects of antibacterial agents on Mycoplasma agalactiae, Mycoplasma putrefaciens, Mycoplasma capricolum subsp. capricolum, and Mycoplasma mycoides subsp. mycoides large colony type.
    Assunção P; Antunes NT; Rosales RS; Poveda C; Poveda JB; Davey HM
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2845-9. PubMed ID: 16870783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.
    Vicca J; Stakenborg T; Maes D; Butaye P; Peeters J; de Kruif A; Haesebrouck F
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4470-2. PubMed ID: 15504886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm formation and determination of minimum biofilm eradication concentration of antibiotics in Mycoplasma hyopneumoniae.
    Tassew DD; Mechesso AF; Park NH; Song JB; Shur JW; Park SC
    J Vet Med Sci; 2017 Oct; 79(10):1716-1720. PubMed ID: 28890520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical meaning of the determination of the minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) (author's transl)].
    Sanfilippo A
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():517-22. PubMed ID: 555528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic integration and resistance of tiamulin against Mycoplasma hyopneumoniae in an in vitro dynamic model.
    Huang Z; Xia X; Mao C; Gu X; Shen X; Yang H; Ding H
    Microb Pathog; 2020 Oct; 147():104255. PubMed ID: 32407861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.